Dong Xun Wu

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.

QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing.